Clinical trial
Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
NCT00037843 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00037843 |
|---|---|
| Title | Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening |
| Official title | Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | University of Michigan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adrenal Gland Diseases, Adrenal Gland Neoplasms |
| Intervention type | Drug |
| Interventions | I-131 Iodocholesterol |
| Enrollment | 114 |
| Start date | Dec 1, 1988 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | May 24, 2002 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: